Sonia Molina Pinelo

Title: Sonia Molina Pinelo: Innovator in Lung Cancer Treatment Prediction

Introduction

Sonia Molina Pinelo is a distinguished inventor based in Seville, Spain. She has made significant contributions to the field of cancer treatment, particularly in predicting patient responses to therapies. Her innovative work focuses on improving therapeutic decision-making for lung cancer patients.

Latest Patents

Sonia holds a patent for a method that utilizes N-cadherin and FGFR1 and/or FGFR4 to predict the response of patients to lung cancer treatment. The invention describes a method for assessing how subjects suffering from lung cancer respond to FGFR inhibitors. By analyzing the expression of specific biomarkers, clinicians can classify patients as responsive or unresponsive to treatment. This classification aids in optimizing treatment plans, allowing unresponsive patients to receive alternative therapies.

Career Highlights

Throughout her career, Sonia has worked with notable institutions such as Fundación de Investigación Hospital 12 de Octubre and Servicio Andaluz de Salud. Her experience in these organizations has contributed to her expertise in cancer research and treatment methodologies.

Collaborations

Sonia has collaborated with esteemed colleagues, including Luis Paz-Ares Rodríguez and Álvaro Quintanal Villalonga. These partnerships have furthered her research and innovation in the medical field.

Conclusion

Sonia Molina Pinelo is a pioneering inventor whose work in lung cancer treatment prediction is making a significant impact in the medical community. Her innovative methods are enhancing patient care and treatment outcomes.